Rationality Evaluation of Antihypertension Drug Use in dr. Soegiri Hospital Lamongan at 2017

Authors

  • Dian Sa'idah Universitas Islam Negeri Maulana Malik Ibrahim Malang ,
  • Hajar Sugihantoro Universitas Islam Negeri Maulana Malik Ibrahim Malang ,
  • Abdul Hakim Universitas Islam Negeri Maulana Malik Ibrahim Malang ,
  • Siti Maimunah Universitas Islam Negeri Maulana Malik Ibrahim Malang ,

DOI:

https://doi.org/10.35814/jifi.v17i1.650

Keywords:

Hypertension, antihypertensive drugs, rationality evaluation

Abstract

Hypertension is a non-communicable disease characterized by increased blood pressure that reaches > 140/90 mmHg. The incidence of hypertension and its complications continues to increase every year so the potential for irrational use of drugs is also increasing.  The purpose of this study was to determine the rationality of the use of antihypertensive drugs at the outpatient installation of Hospital Dr. Soegiri Lamongan in the 2017 period, which reviews the exact indication, the right patient, the right drug, and the right dosage. This study is an observational study conducted by descriptive method and uses retrospective data, namely medical record sheets of hypertensive patients in 2017.  The sampling method used was proportional stratified random sampling. The study population was 451 medical records of hypertensive patients, the number of samples used was 82 medical records where there were 269 prescription sheets in it. The data obtained are then compared using the 2013 American Society of Hypertension (ASH) literature and 2017 Hypertension Clinical Guidelines. The results showed that the rationality of the use of antihypertensive drugs in Dr. Soegiri Lamongan Hospital in 2017 period is 100% accurate on indications, 91,82 % right on patients, 88,85% right on drugs, and 98,14% right on dosages.

References

Downloads

Published

2019-04-24

Issue

Vol. 17 No. 1 (2019): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.